ArticleZeitschrift fur Rheumatologie2023

Real-world treatment persistence in patients with rheumatoid arthritis initiating DMARDs in Germany-a health insurance claims data analysis.

Christoph Fiehn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.